PUBLISHER: The Business Research Company | PRODUCT CODE: 1720747
PUBLISHER: The Business Research Company | PRODUCT CODE: 1720747
Chikungunya Global Market Report 2025
Chikungunya (CHIKV) is a viral infection caused by the chikungunya virus, primarily transmitted to humans through the bites of infected Aedes aegypti and Aedes albopictus mosquitoes. The infection causes symptoms such as fever, joint pain, headache, rash, and muscle pain, which significantly affect the quality of life of those who are infected.
The main product types for chikungunya include antiviral drugs, herbal and complementary treatments, supportive care, and vaccines. Antiviral drugs are designed to prevent or treat viral infections by inhibiting the replication of viruses in the body. These medications come in various forms, such as liquids, powders, and solids, and are used at different stages of the disease, including acute, chronic, and post-infection stages. These products are distributed through a variety of sales channels, including hospital pharmacies, online pharmacies, retail pharmacies, and supermarkets, and are used by various end users such as caregivers, healthcare professionals, and patients.
The chikungunya market research report is one of a series of new reports from The Business Research Company that provides chikungunya market statistics, including the chikungunya industry global market size, regional shares, competitors with the chikungunya market share, detailed chikungunya market segments, market trends, and opportunities, and any further data you may need to thrive in the chikungunya industry. This chikungunya market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The chikungunya market size has grown strongly in recent years. It will grow from $0.59 billion in 2024 to $0.65 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth during the historic period can be attributed to factors such as rising per capita healthcare expenditures, the growing prevalence of emerging and re-emerging infectious diseases, increased personal disposable income, climate change, and heightened awareness of mosquito-borne diseases.
The chikungunya market size is expected to see strong growth in the next few years. It will grow to $0.93 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth during the forecast period can be attributed to factors such as a global increase in clinical trials, a growing geriatric population, a rising demand for immunization, expanding government and non-government initiatives, increased government investments, and favorable policies. Key trends during this period include advancements in biotechnology for vaccine development, new opportunities in vaccine research, the use of CRISPR and AI for innovative solutions, strategic collaborations among pharmaceutical companies, and the integration of telemedicine services.
The increasing prevalence of mosquito-borne diseases is expected to drive the growth of the chikungunya market in the coming years. Mosquito-borne diseases, including chikungunya, dengue, and the Zika virus, are transmitted to humans through infected Aedes mosquitoes and present significant global public health challenges. The rising incidence of these diseases is influenced by factors such as climate change, urbanization, deforestation, stagnant water accumulation, insufficient vector control measures, increased global travel, and insecticide resistance. Chikungunya treatment helps patients by alleviating symptoms such as fever, joint pain, and inflammation, improving overall comfort and mobility, reducing complications, and promoting recovery through hydration, pain management, and supportive care. For instance, in December 2024, the UK Health Security Agency reported that between January and June 2024, the number of dengue cases among returning travelers in England, Wales, and Northern Ireland surged to 473, a 201% increase compared to the 157 cases reported during the same period in 2023. This growing global incidence of mosquito-borne diseases is fueling the growth of the chikungunya market.
Leading companies in the chikungunya market are focusing on the development of innovative vaccines to enhance immunity, prevent disease outbreaks, and address the rising global health burden of chikungunya virus infections. One such innovation is the live attenuated chikungunya vaccine, which uses a weakened form of the virus to stimulate an immune response without causing the disease, providing long-term protection. For example, in November 2023, Valneva SE, a France-based biotechnology company, announced the approval of IXCHIQ, a live attenuated chikungunya vaccine, by the U.S. Food and Drug Administration (FDA). This approval was granted under accelerated approval based on anti-CHIKV neutralizing antibody titers, with continued approval contingent on confirming clinical benefits in further studies. Valneva also received a Priority Review Voucher (PRV) from the FDA, which it plans to monetize to support its research and development efforts. IXCHIQ is administered as a single-dose injection and contains a live, weakened form of the chikungunya virus, which may cause mild symptoms similar to the disease.
In February 2023, Bavarian Nordic A/S, a Denmark-based biotechnology company, acquired the travel vaccine portfolio from Emergent BioSolutions Inc. for USD 380 million. This acquisition aims to strengthen Bavarian Nordic's position in the travel vaccine market by adding marketed vaccines such as Vivotif for typhoid fever prevention, Vaxchora for cholera prevention, and a phase 3 vaccine candidate for chikungunya virus prevention. Emergent BioSolutions Inc., a US-based life sciences company, also offers chikungunya vaccines.
Major players in the chikungunya market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Quest Diagnostics Incorporated, Eurofins Scientific SE, Grifols Diagnostic Solutions Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Euroimmun AG, Evotec SE, Valneva SE, ELITechGroup S.A.S., Vaxart Inc., BioPerfectus Biotechnology Co. Ltd., CTK Biotech Inc., Creative Diagnostics Inc., Inovio Pharmaceuticals Inc., Biotrol Laboratories Pvt. Ltd.
North America was the largest region in the chikungunya market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chikungunya report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the chikungunya market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chikungunya market consists of revenues earned by entities by providing services such as vaccination services, diagnostic testing services, and consultation and medical care. The market value includes the value of related goods sold by the service provider or included within the service offering. The chikungunya market also includes sales of vaccines, diagnostic kits, supportive therapies, and diagnostic equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chikungunya Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chikungunya market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chikungunya ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chikungunya market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Antiviral Drugs; Herbal And Complementary Treatments; Supportive Care; Vaccines
- 2) By Product Form: Liquid Form; Powder; Solid Form
- 3) By Disease Stage: Acute; Chronic; Post-Infection
- 4) By Sales Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies; Supermarkets
- 5) By End User: Caregivers; Healthcare Professionals; Patients
- Subsegments:
- 1) By Antiviral Drugs: Nucleoside Analogues; Protease Inhibitors
- 2) By Herbal And Complementary Treatments: Ayurvedic Remedies; Homeopathic Treatments; Traditional Chinese Medicine
- 3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen); Fluid Therapy; Physiotherapy
- 4) By Vaccines: Live-Attenuated Vaccines; Inactivated Vaccines; mRNA-Based Vaccines
- Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Quest Diagnostics Incorporated
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Chikungunya Market Characteristics
3. Chikungunya Market Trends And Strategies
4. Chikungunya Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Chikungunya Growth Analysis And Strategic Analysis Framework
- 5.1. Global Chikungunya PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Chikungunya Market Growth Rate Analysis
- 5.4. Global Chikungunya Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Chikungunya Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Chikungunya Total Addressable Market (TAM)
6. Chikungunya Market Segmentation
- 6.1. Global Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antiviral Drugs
- Herbal And Complementary Treatments
- Supportive Care
- Vaccines
- 6.2. Global Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Liquid Form
- Powder
- Solid Form
- 6.3. Global Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute
- Chronic
- Post-Infection
- 6.4. Global Chikungunya Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Supermarkets
- 6.5. Global Chikungunya Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Caregivers
- Healthcare Professionals
- Patients
- 6.6. Global Chikungunya Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nucleoside Analogues
- Protease Inhibitors
- 6.7. Global Chikungunya Market, Sub-Segmentation Of Herbal And Complementary Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ayurvedic Remedies
- Homeopathic Treatments
- Traditional Chinese Medicine
- 6.8. Global Chikungunya Market, Sub-Segmentation Of Supportive Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pain Relievers (NSAIDs, Acetaminophen)
- Fluid Therapy
- Physiotherapy
- 6.9. Global Chikungunya Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Live-Attenuated Vaccines
- Inactivated Vaccines
- mRNA-Based Vaccines
7. Chikungunya Market Regional And Country Analysis
- 7.1. Global Chikungunya Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Chikungunya Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Chikungunya Market
- 8.1. Asia-Pacific Chikungunya Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Chikungunya Market
- 9.1. China Chikungunya Market Overview
- 9.2. China Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Chikungunya Market
- 10.1. India Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Chikungunya Market
- 11.1. Japan Chikungunya Market Overview
- 11.2. Japan Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Chikungunya Market
- 12.1. Australia Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Chikungunya Market
- 13.1. Indonesia Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Chikungunya Market
- 14.1. South Korea Chikungunya Market Overview
- 14.2. South Korea Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Chikungunya Market
- 15.1. Western Europe Chikungunya Market Overview
- 15.2. Western Europe Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Chikungunya Market
- 16.1. UK Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Chikungunya Market
- 17.1. Germany Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Chikungunya Market
- 18.1. France Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Chikungunya Market
- 19.1. Italy Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Chikungunya Market
- 20.1. Spain Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Chikungunya Market
- 21.1. Eastern Europe Chikungunya Market Overview
- 21.2. Eastern Europe Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Chikungunya Market
- 22.1. Russia Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Chikungunya Market
- 23.1. North America Chikungunya Market Overview
- 23.2. North America Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Chikungunya Market
- 24.1. USA Chikungunya Market Overview
- 24.2. USA Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Chikungunya Market
- 25.1. Canada Chikungunya Market Overview
- 25.2. Canada Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Chikungunya Market
- 26.1. South America Chikungunya Market Overview
- 26.2. South America Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Chikungunya Market
- 27.1. Brazil Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Chikungunya Market
- 28.1. Middle East Chikungunya Market Overview
- 28.2. Middle East Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Chikungunya Market
- 29.1. Africa Chikungunya Market Overview
- 29.2. Africa Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Chikungunya Market Competitive Landscape And Company Profiles
- 30.1. Chikungunya Market Competitive Landscape
- 30.2. Chikungunya Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
31. Chikungunya Market Other Major And Innovative Companies
- 31.1. Eurofins Scientific SE
- 31.2. Grifols Diagnostic Solutions Inc.
- 31.3. bioMerieux SA
- 31.4. Bio-Rad Laboratories Inc.
- 31.5. DiaSorin S.p.A.
- 31.6. Euroimmun AG
- 31.7. Evotec SE
- 31.8. Valneva SE
- 31.9. ELITechGroup S.A.S.
- 31.10. Vaxart Inc.
- 31.11. BioPerfectus Biotechnology Co. Ltd.
- 31.12. CTK Biotech Inc.
- 31.13. Creative Diagnostics Inc.
- 31.14. Inovio Pharmaceuticals Inc.
- 31.15. Biotrol Laboratories Pvt. Ltd.
32. Global Chikungunya Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Chikungunya Market
34. Recent Developments In The Chikungunya Market
35. Chikungunya Market High Potential Countries, Segments and Strategies
- 35.1 Chikungunya Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Chikungunya Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Chikungunya Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
